Date | Title | |
---|---|---|
28 Sep 2021 |
Artios Doses First Patient in Phase 1/2a Study of Polθ Inhibitor ART4215 |
|
28 Sep 2021 | ||
28 Sep 2021 | ||
23 Sep 2021 |
Itaconix plc |
|
23 Sep 2021 |
Xeros Technology Group plc |
|
22 Sep 2021 |
Mirriad Advertising Ltd |
|
22 Sep 2021 |
DeepMatter Group plc |
|
20 Sep 2021 | ||
20 Sep 2021 |
Mirriad Advertising Ltd |
|
15 Sep 2021 |
Actual Experience Ltd |
|
Load more1132 |